Showing results (61-70 of 181) with videos related to

Sort By:
Pageof 19
Molecular Ecology|October 14, 2024
A Latitudinal Gradient of Reference GenomesEthan B Linck, Carlos Daniel Cadena
Current Medical Research and Opinion|March 30, 2018
A real-world analysis of glycemic control among patients with type 2 diabetes treated with canagliflozin versus dapagliflozinLawrence Blonde, Charmi Patel, Brahim Bookhart, et al.
Diabetes & Vascular Disease Research|May 4, 2017
Gaps and barriers in the control of blood glucose in people with type 2 diabetesLawrence Blonde, Pablo Aschner, Clifford Bailey, et al.
Diabetes, Obesity & Metabolism|October 22, 2016
Predictors of outcomes in patients with type 2 diabetes in the lixisenatide GetGoal clinical trialsLawrence Blonde, Pavan Chava, Terry Dex, et al.
The American Journal of Managed Care|March 4, 2015
Diabetes-related quality measure attainment: canagliflozin versus sitagliptin based on a pooled analysis of 2 clinical trialsRobert A Bailey, Ujjwala Vijapurkar, Gary E Meininger, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|January 23, 2013
The role of bromocriptine-QR in the management of type 2 diabetes expert panel recommendationsAlan J Garber, Lawrence Blonde, Zachary T Bloomgarden, et al.
Ochsner Journal|May 24, 2011
Quality of care indicators, health behaviors, and physical functioning in adults with diabetesMarie Krousel-Wood, David M Radosevich, Clese Erikson, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|March 14, 2020
Fixed-Ratio Combination of Insulin and GLP-1 RA in Patients with Longstanding Type 2 Diabetes: A Subanalysis of LixiLan-LLawrence Blonde, Lori Berard, Aramesh Saremi, et al.
Pageof 19